Medical Journals

Arterial Remodeling and Plasma Volume Expansion in Caveolin-1-deficient Mice.

Authors:
  • Albinsson Sebastian
  • Shakirova Yulia
  • Rippe Anna
  • Baumgarten Maria
  • Rosengren Bert-Inge
  • Rippe Catarina
  • Hallmann Rupert
  • Hellstrand Per
  • Rippe Bengt
  • Swärd Karl

From: Department of Experimental Medical Science, Lund University, SE-221 84 Lund, Sweden.

American journal of physiology. Regulatory, integrative and comparative physiology

  • Publish Date: Sep 2007
  • ISSN: 0363-6119
  • Volume: 293
  • Issue: 3
  • Pages: R1222-31
  • Medium: Print
  • Language: English
  • Citation (JAMA): Albinsson Sebastian, Shakirova Yulia, Rippe Anna, et al. Arterial Remodeling and Plasma Volume Expansion in Caveolin-1-deficient Mice.. Am. J. Physiol. Regul. Integr. Comp. Physiol. Sep 2007;293:R1222-31

Abstract

Caveolin-1 (Cav-1) is essential for the morphology of membrane caveolae and exerts a negative influence on a number of signaling systems, including nitric oxide (NO) production and activity of the MAP kinase cascade. In the vascular system, ablation of caveolin-1 may thus be expected to cause arterial dilatation and increased vessel wall mass (remodeling). This was tested in Cav-1 knockout (KO) mice by a detailed morphometric and functional analysis of mesenteric resistance arteries, shown to lack caveolae. Quantitative morphometry revealed increased media thickness and media-to-lumen ratio in KO. Pressure-induced myogenic tone and flow-induced dilatation were decreased in KO arteries, but both were increased toward wild-type (WT) levels following NO synthase (NOS) inhibition. Isometric force recordings following NOS inhibition showed rightward shifts of passive and active length-force relationships in KO, and the force response to alpha(1)-adrenergic stimulation was increased. In contrast, media thickness and force response of the aorta were unaltered in KO vs. WT, whereas lumen diameter was increased. Mean arterial blood pressure during isoflurane anesthesia was not different in KO vs. WT, but greater fluctuation in blood pressure over time was noted. Following NOS inhibition, fluctuations disappeared and pressure increased twice as much in KO (38 +/- 6%) compared with WT (17 +/- 3%). Tracer-dilution experiments showed increased plasma volume in KO. We conclude that NO affects blood pressure more in Cav-1 KO than in WT mice and that restructuring of resistance vessels and an increased responsiveness to adrenergic stimulation compensate for a decreased tone in Cav-1 KO mice.

Mesh Headings (Keywords): Animals, Blood Pressure, Blotting, Western, Caveolin 1, Enzyme Inhibitors, Fluorescent Antibody Technique, Isometric Contraction, Kinetics, Mesenteric Arteries, Mice, Mice, Inbred C57BL, Mice, Knockout, Microscopy, Electron, Transmission, Muscle Contraction, Muscle Tonus, Myography, NG-Nitroarginine Methyl Ester, Nitric Oxide Synthase Type III, Organ Culture Techniques, Plasma Substitutes, Plasma Volume, Thymidine, Vasodilation


Check for Full Text / PubMed Unique Identifier (PMID): 17626133


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.